Home › Funds › Tetragon Partners GP Ltd › AXSM

Tetragon Partners GP Ltd position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

Tetragon Partners GP Ltd reported holding 35,000 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$8.6M, representing 1.40% of its reported portfolio and ranking #16 among its reported holdings. Tetragon Partners GP Ltd has disclosed AXSM holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)35.00K sh
Reported value held$8.57M
Portfolio Weight1.40%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tetragon Partners GP Ltd's AXSM position evolved

Tetragon Partners GP Ltd first disclosed a stake in AXSM in Q4 2024 at 41,250 shares (US$3.5M). The position peaked in Q2 2026 at 35,000 shares, worth US$8.6M. Across 7 filings, Tetragon Partners GP Ltd increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 35,000 shares valued at US$8.6M — an increase of 14,941 shares quarter over quarter.. Notable position changes include a 42% trim in Q4 2025 (shares fell 7% over the following quarter), a 26% trim in Q1 2026 (shares rose 45% over the following quarter), a 74% increase in Q2 2026 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 41.25K $3.49M New
Q1 2025 33.81K $3.94M Reduce
Q2 2025 41.53K $4.34M Add
Q3 2025 46.46K $5.64M Add
Q4 2025 26.93K $4.92M Reduce
Q1 2026 20.06K $3.39M Reduce
Q2 2026 35.00K $8.57M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 54 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has Tetragon Partners GP Ltd held AXSM?

Tetragon Partners GP Ltd has disclosed AXSM holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Tetragon Partners GP Ltd's current position in AXSM?

As of Q2 2026, Tetragon Partners GP Ltd holds 35.00K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $8.57M, representing 1.40% of its reported portfolio and ranking #16.

Has Tetragon Partners GP Ltd been buying or selling AXSM?

In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd increased its position in AXSM. The position peaked in Q2 2026 at 35.00K shares.

Which other funds hold AXSM?

Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.